KERRON

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Levetiracetam

Available from:

Aurobindo Pharma Australia Pty Ltd

Class:

Medicine Registered

Patient Information leaflet

KERRON 

CONSUMER MEDICINE INFORMATION

Ver 1.1

Page 1 of 4 

KERRON 250, 500, 750 & 1000  
Levetiracetam 
CONSUMER MEDICINE INFORMATION 

WHAT IS IN THIS LEAFLET 

This leaflet answers some common 
questions about KERRON. 

It does not contain all the available 
information. It does not take the place 
of talking to your doctor or 
pharmacist. 

All medicines have risks and benefits. 
Your doctor has weighed the risks of 
you taking KERRON against the 
benefits they expect it will have for 
you. 

IF YOU HAVE ANY CONCERNS ABOUT 
TAKING THIS MEDICINE, ASK YOUR 
DOCTOR OR PHARMACIST.  

KEEP THIS LEAFLET WITH THE MEDICINE.  
You may need to read it again. 

WHAT KERRON USED FOR 

KERRON is used to control epilepsy. 

Epilepsy is a condition where you 
have repeated seizures. There are 
many different types of seizures, 
ranging from mild to severe. 

This medicine belongs to a group of 
medicines called antiepileptics. These 
medicines are thought to work by 
controlling brain chemicals which 
send signals to nerves so that seizures 
do not happen.   

KERRON may be used alone, or in 
combination with other medicines, to 
treat your condition. 

Your doctor may have prescribed this 
medicine in addition to your current 
therapy. 

ASK YOUR DOCTOR IF YOU HAVE ANY 
QUESTIONS ABOUT WHY THIS MEDICINE 
HAS BEEN PRESCRIBED FOR YOU. 

There is no evidence that this 
medicine is addictive. 
This medicine is available only with a 
doctor’s prescription. 

The safety and effectiveness of 
KERRON has not been established in 
patients less than 4 years of age. 

BEFORE YOU TAKE KERRON  

WHEN YOU MUST NOT TAKE IT  

Do not take KERRON if you have an 
allergy to:  
•  any of the ingredients listed at the 
end of this leaflet.  

Some of the symptoms of an allergic 
reaction may in

Summary of Product characteristics

 
Product Information:   
KERRON (Levetiracetam Tablets 250, 500, 750 & 1000 mg)    

                                 Ver 1.1 

Page 1 of 23 

PRODUCT INFORMATION 

KERRON 250 (250 MG LEVETIRACETAM) 
KERRON 500 (500 MG LEVETIRACETAM) 
KERRON 750 (750 MG LEVETIRACETAM) 
KERRON 1000 (1000 MG LEVETIRACETAM) 

NAME OF THE MEDICINE 
The name of the medicine is levetiracetam. 

N
O
O
N H
2
C H
3
*

CHEMICAL NAME: (_α_S)-α-ethyl-2-oxo-1-pyrrolidineacetamide 
MOLECULAR FORMULA: C
8
H
14
N
2
O
2 
MOLECULAR WEIGHT: 170.21 
CAS REGISTRY NUMBER: _[102767-28-2]_
 _ _

DESCRIPTION  
Levetiracetam is white or almost white powder. It is Very soluble in
water, soluble in acetonitrile, 
practically insoluble in hexane. 

KERRON tablets contain the following inactive ingredients: Maize
starch, colloidal anhydrous 
silica, povidone, purified talc & magnesium stearate. 
250 mg tablet also contains Opadry OY-S-30913 BLUE (PI-ARTG
No.3804). 
500 mg tablet also contains Opadry Complete Film Coating
System 05F82840 Yellow (PI-ARTG 
No.106470). 
750 mg tablet also contains Opadry OY-S-33016 Orange (PI-ARTG
No.3803).

1000 mg tablet also contains Opadry White Y-1-7000 E171 (PI-ARTG
No.2731).

PHARMACOLOGY 
MECHANISM OF ACTION 
The precise mechanism of action by which levetiracetam induces
seizure protection still remains 
to be fully elucidated, but appears to be unrelated to the
mechanisms of current anti-epileptic 
drugs. In vitro and in vivo experiments suggest that
levetiracetam does not alter basic cell 
characteristics and normal neurotransmission. 

In vitro studies show that levetiracetam affects intraneuronal Ca
2+
 levels by partial inhibition of 
N-type Ca
2+
 currents and by reducing the release of Ca
2+
 from intraneuronal stores. In addition, it 
partially reverses the reductions in GABA- and glycine-gated currents
induced by zinc and�